Amgen, Pfizer eye blockbuster purse in next leg of PCSK9 cholesterol drug race

By Ryan McBride Amgen ($AMGN) is readying to lift the curtain on data from four mid-stage studies for a major star in its experimental drug pipeline. The monoclonal antibody, AMG-145, ...

UPDATE 2-Vertex posts loss as hepatitis drug sales fall

* 3rd quarter net loss 27 cents a share * Incivek sales fall 40 pct to $254.3 million * Still sees 2012 Incivek sales $1.1 bln to $1.25 bln * Shares fall 4.3 percent after hours (Adds ...

Valeant Pharma Q3 Profit Declines; Tightens Q4, 2012 EPS Outlook

(RTTNews.com) – Canadian drug maker Valeant Pharmaceuticals International, Inc. (VRX, VRX.TO) reported Friday a profit for the third quarter that declined from last year, hurt ...

Teva swings to loss on charges but sales growth is strong

By KEVIN GROGAN Teva Pharmaceutical Industries has posted a loss of $79 million for the third quarter, compared with net income of $916 million in the like, year-earlier period, hit ...

Boehringer, Ensemble join forces to discover macrocycle drugs

PBR Staff Writer Ensemble Therapeutics has initiated a research collaboration with Boehringer Ingelheim to discover drug candidates for a new class of small molecule drugs, macrocycles ...

Lilly to Expand Indianapolis Insulin Manufacturing…

By Eli Lilly and Company INDIANAPOLIS , Nov. 1, 2012 /PRNewswire/ — Local and state government officials joined representatives from Eli Lilly and Company (NYSE: LLY) today ...

3 Critical Answers for MannKind

By Keith Speights Hurricane Sandy delayed the release of third-quarter results for pharmaceutical company MannKind(Nasdaq: MNKD  ) , but now we know the story. MannKind beat expectations ...

How Does The Patent Exclusivity Factor Affect The 3 Top Dividend-Paying Healthcare Companies?

By Ed Liston The message that the company you invested in has sent a dividend check your way does not fail to bring a smile to even the most diehard appreciation-oriented investor. ...

Nestle Wins Clearance in China for Pfizer-Unit Purchase

By Dermot Doherty Nestle SA (NESN), the world’s largest food company, won regulatory approval in China for its $11.9 billion acquisition of Pfizer Inc. (PFE)’s infant-nutrition ...

Pacira Pharmaceuticals Beats on the Top Line

By Seth Jayson Pacira Pharmaceuticals (Nasdaq: PCRX  ) reported earnings on Nov. 1. Here are the numbers you need to know. The 10-second takeaway For the quarter ended Sep. 30 ...

Isis To Receive $1.25 Million Payment As Pfizer Continues Development Of EXC 001

CARLSBAD, Calif., Nov. 2, 2012 /PRNewswire/ — Isis Pharmaceuticals, Inc. (ISIS) announced today that it will receive a $1.25 million contingent payment from Pfizer Inc. (PFE) ...

Dendreon: What’s The Company Worth Per Share?

By Theodore Cohen I concluded my most recent article on Dendreon (DNDN) with the plea: “Lord, show me a sign.” Whether or not that had anything to do with theresults released ...
Page 20 of 93« First...10...1819202122...304050...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS